Table 1. Clinicopathological characteristics of clinical samples and expression of MACC1 in liver cancer.
| Characteristics | No. patients | (%) |
| Age (years) | ||
| ≤50 | 182 | (59.1) |
| >50 | 126 | (40.9) |
| Gender | ||
| male | 249 | (80.8) |
| female | 59 | (19.2) |
| TNM classification | ||
| I | 26 | (8.4) |
| II | 195 | (63.3) |
| III | 61 | (19.8) |
| IV | 26 | (8.4) |
| HBsAg | ||
| positive | 258 | (88.1) |
| negative | 35 | (11.9) |
| AFP | ||
| >400 ng/ml | 107 | (35.8) |
| ≤400 ng/ml | 192 | (64.2) |
| Tumor size | ||
| >3 cm | 260 | (85.0) |
| ≤3 cm | 46 | (15.0) |
| Tumor number | ||
| >1 | 102 | (33.3) |
| = 1 | 204 | (66.7) |
| Vital status (at follow-up) | ||
| Alive | 161 | (52.3) |
| Death due to liver cancer cause | 147 | (47.7) |
| Expression of MACC1 | ||
| Low expression | 182 | (59.1) |
| High expression | 126 | (40.9) |